journal
https://read.qxmd.com/read/38702523/equitable-implementation-of-a-precision-digital-health-program-for-glucose-management-in-individuals-with-newly-diagnosed-type-1-diabetes
#1
JOURNAL ARTICLE
Priya Prahalad, David Scheinker, Manisha Desai, Victoria Y Ding, Franziska K Bishop, Ming Yeh Lee, Johannes Ferstad, Dessi P Zaharieva, Ananta Addala, Ramesh Johari, Korey Hood, David M Maahs
Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c < 7%), early technology use (continuous glucose monitoring starts <1 month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study 1)...
May 3, 2024: Nature Medicine
https://read.qxmd.com/read/38693248/adapting-vision-language-ai-models-to-cardiology-tasks
#2
JOURNAL ARTICLE
Rima Arnaout
No abstract text is available yet for this article.
May 1, 2024: Nature Medicine
https://read.qxmd.com/read/38693247/exome-sequencing-reveals-genetic-heterogeneity-and-clinically-actionable-findings-in-children-with-cerebral-palsy
#3
JOURNAL ARTICLE
Yangong Wang, Yiran Xu, Chongchen Zhou, Ye Cheng, Niu Qiao, Qing Shang, Lei Xia, Juan Song, Chao Gao, Yimeng Qiao, Xiaoli Zhang, Ming Li, Caiyun Ma, Yangyi Fan, Xirui Peng, Silin Wu, Nan Lv, Bingbing Li, Yanyan Sun, Bohao Zhang, Tongchuan Li, Hongwei Li, Jin Zhang, Yu Su, Qiaoli Li, Junying Yuan, Lei Liu, Andres Moreno-De-Luca, Alastair H MacLennan, Jozef Gecz, Dengna Zhu, Xiaoyang Wang, Changlian Zhu, Qinghe Xing
Cerebral palsy (CP) is the most common motor disability in children. To ascertain the role of major genetic variants in the etiology of CP, we conducted exome sequencing on a large-scale cohort with clinical manifestations of CP. The study cohort comprised 505 girls and 1,073 boys. Utilizing the current gold standard in genetic diagnostics, 387 of these 1,578 children (24.5%) received genetic diagnoses. We identified 412 pathogenic and likely pathogenic (P/LP) variants across 219 genes associated with neurodevelopmental disorders, and 59 P/LP copy number variants...
May 1, 2024: Nature Medicine
https://read.qxmd.com/read/38689063/microbiome-confounders-and-quantitative-profiling-challenge-predicted-microbial-targets-in-colorectal-cancer-development
#4
JOURNAL ARTICLE
Raúl Y Tito, Sara Verbandt, Marta Aguirre Vazquez, Leo Lahti, Chloe Verspecht, Verónica Lloréns-Rico, Sara Vieira-Silva, Janine Arts, Gwen Falony, Evelien Dekker, Joke Reumers, Sabine Tejpar, Jeroen Raes
Despite substantial progress in cancer microbiome research, recognized confounders and advances in absolute microbiome quantification remain underused; this raises concerns regarding potential spurious associations. Here we study the fecal microbiota of 589 patients at different colorectal cancer (CRC) stages and compare observations with up to 15 published studies (4,439 patients and controls total). Using quantitative microbiome profiling based on 16S ribosomal RNA amplicon sequencing, combined with rigorous confounder control, we identified transit time, fecal calprotectin (intestinal inflammation) and body mass index as primary microbial covariates, superseding variance explained by CRC diagnostic groups...
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38689062/vision-language-foundation-model-for-echocardiogram-interpretation
#5
JOURNAL ARTICLE
Matthew Christensen, Milos Vukadinovic, Neal Yuan, David Ouyang
The development of robust artificial intelligence models for echocardiography has been limited by the availability of annotated clinical data. Here, to address this challenge and improve the performance of cardiac imaging models, we developed EchoCLIP, a vision-language foundation model for echocardiography, that learns the relationship between cardiac ultrasound images and the interpretations of expert cardiologists across a wide range of patients and indications for imaging. After training on 1,032,975 cardiac ultrasound videos and corresponding expert text, EchoCLIP performs well on a diverse range of benchmarks for cardiac image interpretation, despite not having been explicitly trained for individual interpretation tasks...
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38689061/the-search-for-authentic-microbiome-disease-relationships
#6
JOURNAL ARTICLE
Na Jiao, Lixin Zhu, Ruixin Zhu
No abstract text is available yet for this article.
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38689060/neoadjuvant-nivolumab-with-or-without-relatlimab-in-resectable-non-small-cell-lung-cancer-a-randomized-phase-2-trial
#7
JOURNAL ARTICLE
Martin Schuler, Kristof Cuppens, Till Plönes, Marcel Wiesweg, Bert Du Pont, Balazs Hegedus, Johannes Köster, Fabian Mairinger, Kaid Darwiche, Annette Paschen, Brigitte Maes, Michel Vanbockrijck, David Lähnemann, Fang Zhao, Hubertus Hautzel, Dirk Theegarten, Koen Hartemink, Henning Reis, Paul Baas, Alexander Schramm, Clemens Aigner
Antibodies targeting the immune checkpoint molecules PD-1, PD-L1 and CTLA-4, administered alone or in combination with chemotherapy, are the standard of care in most patients with metastatic non-small-cell lung cancers. When given before curative surgery, tumor responses and improved event-free survival are achieved. New antibody combinations may be more efficacious and tolerable. In an ongoing, open-label phase 2 study, 60 biomarker-unselected, treatment-naive patients with resectable non-small-cell lung cancer were randomized to receive two preoperative doses of nivolumab (anti-PD-1) with or without relatlimab (anti-LAG-3) antibody therapy...
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38689059/correlates-of-protection-against-symptomatic-sars-cov-2-in-vaccinated-children
#8
JOURNAL ARTICLE
Youjia Zhong, Alicia Y H Kang, Carina J X Tay, Hui' En Li, Nurul Elyana, Chee Wah Tan, Wee Chee Yap, Joey M E Lim, Nina Le Bert, Kuan Rong Chan, Eugenia Z Ong, Jenny G Low, Lynette P Shek, Elizabeth Huiwen Tham, Eng Eong Ooi
The paucity of information on longevity of vaccine-induced immune responses and uncertainty of the correlates of protection hinder the development of evidence-based COVID-19 vaccination policies for new birth cohorts. Here, to address these knowledge gaps, we conducted a cohort study of healthy 5-12-year-olds vaccinated with BNT162b2. We serially measured binding and neutralizing antibody titers (nAbs), spike-specific memory B cell (MBC) and spike-reactive T cell responses over 1 year. We found that children mounted antibody, MBC and T cell responses after two doses of BNT162b2, with higher antibody and T cell responses than adults 6 months after vaccination...
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38689058/life-long-health-consequences-of-undernutrition-in-the-yanomami-indigenous-population-in-brazil
#9
LETTER
Thiago Dos Reis Araujo, Ana Paula Davel, Everardo Magalhães Carneiro
No abstract text is available yet for this article.
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38688996/sustainable-low-cost-cancer-diagnostics
#10
Karen O'Leary
No abstract text is available yet for this article.
April 30, 2024: Nature Medicine
https://read.qxmd.com/read/38684932/telemonitoring-of-patients-with-acute-coronary-syndrome
#11
Sonia Muliyil
No abstract text is available yet for this article.
April 29, 2024: Nature Medicine
https://read.qxmd.com/read/38684861/influence-of-covid-19-on-trust-in-routine-immunization-health-information-sources-and-pandemic-preparedness-in-23-countries-in-2023
#12
JOURNAL ARTICLE
Jeffrey V Lazarus, Trenton M White, Katarzyna Wyka, Scott C Ratzan, Kenneth Rabin, Heidi J Larson, Federico Martinon-Torres, Ernest Kuchar, Salim S Abdool Karim, Tamara Giles-Vernick, Selina Müller, Carolina Batista, Nellie Myburgh, Beate Kampmann, Ayman El-Mohandes
It is unclear how great a challenge pandemic and vaccine fatigue present to public health. We assessed perspectives on coronavirus disease 2019 (COVID-19) and routine immunization as well as trust in pandemic information sources and future pandemic preparedness in a survey of 23,000 adults in 23 countries in October 2023. The participants reported a lower intent to get a COVID-19 booster vaccine in 2023 (71.6%), compared with 2022 (87.9%). A total of 60.8% expressed being more willing to get vaccinated for diseases other than COVID-19 as a result of their experience during the pandemic, while 23...
April 29, 2024: Nature Medicine
https://read.qxmd.com/read/38684860/ai-enabled-electrocardiography-alert-intervention-and-all-cause-mortality-a-pragmatic-randomized-clinical-trial
#13
JOURNAL ARTICLE
Chin-Sheng Lin, Wei-Ting Liu, Dung-Jang Tsai, Yu-Sheng Lou, Chiao-Hsiang Chang, Chiao-Chin Lee, Wen-Hui Fang, Chih-Chia Wang, Yen-Yuan Chen, Wei-Shiang Lin, Cheng-Chung Cheng, Chia-Cheng Lee, Chih-Hung Wang, Chien-Sung Tsai, Shih-Hua Lin, Chin Lin
The early identification of vulnerable patients has the potential to improve outcomes but poses a substantial challenge in clinical practice. This study evaluated the ability of an artificial intelligence (AI)-enabled electrocardiogram (ECG) to identify hospitalized patients with a high risk of mortality in a multisite randomized controlled trial involving 39 physicians and 15,965 patients. The AI-ECG alert intervention included an AI report and warning messages delivered to the physicians, flagging patients predicted to be at high risk of mortality...
April 29, 2024: Nature Medicine
https://read.qxmd.com/read/38684859/the-health-risks-of-generative-ai-based-wellness-apps
#14
REVIEW
Julian De Freitas, I Glenn Cohen
Artificial intelligence (AI)-enabled chatbots are increasingly being used to help people manage their mental health. Chatbots for mental health and particularly 'wellness' applications currently exist in a regulatory 'gray area'. Indeed, most generative AI-powered wellness apps will not be reviewed by health regulators. However, recent findings suggest that users of these apps sometimes use them to share mental health problems and even to seek support during crises, and that the apps sometimes respond in a manner that increases the risk of harm to the user, a challenge that the current US regulatory structure is not well equipped to address...
April 29, 2024: Nature Medicine
https://read.qxmd.com/read/38671240/bispecific-t-cell-engager-therapy-for-refractory-rheumatoid-arthritis
#15
JOURNAL ARTICLE
Laura Bucci, Melanie Hagen, Tobias Rothe, Maria Gabriella Raimondo, Filippo Fagni, Carlo Tur, Andreas Wirsching, Jochen Wacker, Artur Wilhelm, Jean-Philippe Auger, Milena Pachowsky, Markus Eckstein, Stefano Alivernini, Angelo Zoli, Gerhard Krönke, Stefan Uderhardt, Aline Bozec, Maria-Antonietta D'Agostino, Georg Schett, Ricardo Grieshaber-Bouyer
Bispecific T cell engagers (BiTEs) kill B cells by engaging T cells. BiTEs are highly effective in acute lymphoblastic leukemia. Here we treated six patients with multidrug-resistant rheumatoid arthritis (RA) with the CD19xCD3 BiTE blinatumomab under compassionate use. Low doses of blinatumomab led to B cell depletion and concomitant decrease of T cells, documenting their engager function. Treatment was safe, with brief increase in body temperature and acute phase proteins during first infusion but no signs of clinically relevant cytokine-release syndrome...
April 26, 2024: Nature Medicine
https://read.qxmd.com/read/38671239/the-argument-framework-is-a-flexible-approach-to-evidence-in-healthcare
#16
JOURNAL ARTICLE
Jonathan Fuller, Benjamin Chin-Yee, Ross E G Upshur
No abstract text is available yet for this article.
April 26, 2024: Nature Medicine
https://read.qxmd.com/read/38664535/large-language-models-for-preventing-medication-direction-errors-in-online-pharmacies
#17
JOURNAL ARTICLE
Cristobal Pais, Jianfeng Liu, Robert Voigt, Vin Gupta, Elizabeth Wade, Mohsen Bayati
Errors in pharmacy medication directions, such as incorrect instructions for dosage or frequency, can increase patient safety risk substantially by raising the chances of adverse drug events. This study explores how integrating domain knowledge with large language models (LLMs)-capable of sophisticated text interpretation and generation-can reduce these errors. We introduce MEDIC (medication direction copilot), a system that emulates the reasoning of pharmacists by prioritizing precise communication of core clinical components of a prescription, such as dosage and frequency...
April 25, 2024: Nature Medicine
https://read.qxmd.com/read/38664534/reproductive-rights-in-the-united-states-acquiescence-is-not-a-strategy
#18
JOURNAL ARTICLE
Laura J Esserman, Douglas Yee
No abstract text is available yet for this article.
April 25, 2024: Nature Medicine
https://read.qxmd.com/read/38653865/new-risk-score-for-cardiovascular-disease-with-improved-performance
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 23, 2024: Nature Medicine
https://read.qxmd.com/read/38653864/nivolumab-for-mismatch-repair-deficient-or-hypermutated-gynecologic-cancers-a-phase-2-trial-with-biomarker-analyses
#20
JOURNAL ARTICLE
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland, Arnaud Da Cruz Paula, Hunter Green, Melih Arda Ozsoy, Alexia Iasonos, Travis Hollmann, Mario M Leitao, Jennifer J Mueller, Vicky Makker, William P Tew, Roisin E O'Cearbhaill, Ying L Liu, Maria M Rubinstein, Tiffany Troso-Sandoval, Stuart M Lichtman, Alison Schram, Chrisann Kyi, Rachel N Grisham, Pamela Causa Andrieu, E John Wherry, Carol Aghajanian, Britta Weigelt, Martee L Hensley, Dmitriy Zamarin
Programmed death-1 (PD-1) inhibitors are approved for therapy of gynecologic cancers with DNA mismatch repair deficiency (dMMR), although predictors of response remain elusive. We conducted a single-arm phase 2 study of nivolumab in 35 patients with dMMR uterine or ovarian cancers. Co-primary endpoints included objective response rate (ORR) and progression-free survival at 24 weeks (PFS24). Secondary endpoints included overall survival (OS), disease control rate (DCR), duration of response (DOR) and safety...
April 23, 2024: Nature Medicine
journal
journal
32162
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.